NIH-funded research R21 grant

Investigating how Candida albicans infects the brain

Official title: Systematic Genetic Analysis of C. albicans CNS Infection

Funded at University of Iowa · NIH-10766813 · Data updated 2026-11-12

This study is looking at how a common fungus called Candida albicans can infect the brain in people with weakened immune systems, like premature babies and certain adults, to find ways to prevent and treat these infections better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$234,319
NIH project number5R21AI173445-02
Project IDNIH-10766813 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include premature infants and adults with mutations in the CARD9 immune pathway who are at high risk for C. albicans CNS infections.

Less likely to help

Patients without a history of Candida infections or those with intact immune systems may not benefit from this research.

What this research studies

This research focuses on understanding how the fungus Candida albicans can infect the central nervous system (CNS), particularly in patients with weakened immune systems. The study will utilize a new model to explore the genetic factors that allow C. albicans to invade the brain, especially in vulnerable populations such as premature infants and adults with specific genetic mutations. By screening various genetic mutants, the research aims to identify key regulators involved in this infection process, which could lead to better prevention and treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and outcomes for patients suffering from CNS infections caused by Candida albicans.

How similar studies have gone: While there has been significant research on fungal infections, this specific approach to understanding C. albicans neurotropism is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Krysan, Damian J — University of Iowa
  • Study coordinator: Krysan, Damian J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.